title: Chapter 1. Molecular mechanism of type IV collagen-derived endogenous inhibitors of angiogenesis.
abstract: Angiogenesis, the process of new blood vessel formation, is regulated on both genetic and molecular levels. Pro- and anti-angiogenic stimuli maintain the angiogenic balance, and the tipping of that balance toward pro-angiogenic activity is critical for tumor growth and survival. Endogenous inhibitors of angiogenesis, many of which are fragments from large extracellular matrix proteins, counter the effect of growth factors and keep angiogenesis in check. This chapter will discuss the molecular mechanisms of endogenous inhibitors derived from type IV collagen and review the in vitro and in vivo assays available to study their role in angiogenesis.
authors.affiliation: Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: Vesselina G
authors.initials: VG
authors.lastname: Cooke
authors.forename: Raghu
authors.initials: R
authors.lastname: Kalluri
mesh_terms: D020533:Angiogenesis Inhibitors / Q000378:metabolism*; D000818:Animals; D002465:Cell Movement; D049109:Cell Proliferation; D024141:Collagen Type IV / Q000378:metabolism*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000378:metabolism* / Q000473:pathology
chemical_list: D020533:Angiogenesis Inhibitors; D024141:Collagen Type IV